Alessandro Lugli Selected Research

Erythema Nodosum

2/2018

Expression Patterns of TNFα, MAdCAM1, and STAT3 in Intestinal and Skin Manifestations of Inflammatory Bowel Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandro Lugli Research Topics

Disease

78	Neoplasms (Cancer) 03/2023 - 10/2003
65	Colorectal Neoplasms (Colorectal Cancer) 09/2023 - 08/2006
20	Neoplasm Metastasis (Metastasis) 03/2023 - 10/2003
10	Colonic Neoplasms (Colon Cancer) 07/2021 - 09/2005
7	Adenocarcinoma 04/2024 - 10/2003
7	Lymphatic Metastasis 11/2023 - 10/2010
5	Rectal Neoplasms (Rectal Cancer) 04/2024 - 06/2010
5	Carcinoma (Carcinomatosis) 07/2014 - 01/2004
4	Adenoma (Adenomas) 04/2016 - 10/2003
4	Microsatellite Instability 01/2012 - 06/2008
3	Disease Progression 01/2019 - 01/2014
2	Polyps 04/2016 - 01/2016
2	Inflammation (Inflammations) 01/2016 - 03/2010
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2011 - 10/2010
2	Prostatic Neoplasms (Prostate Cancer) 12/2009 - 09/2004
2	Hodgkin Disease (Hodgkin's Disease) 11/2003 - 02/2003
1	Extranodal Extension 11/2023
1	Turcot syndrome 01/2022
1	Gastritis 07/2021
1	Cardiac Arrhythmias (Arrythmia) 07/2021
1	Pyoderma 02/2018
1	Erythema Nodosum 02/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2018
1	Monosomy 01/2016

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2004
20	Biomarkers (Surrogate Marker)IBA 04/2024 - 10/2007
11	Keratins (Keratin)IBA 03/2023 - 10/2010
10	Indicators and Reagents (Reagents)IBA 07/2021 - 09/2005
7	ErbB Receptors (EGF Receptor)IBA 12/2011 - 10/2007
6	Eosine Yellowish-(YS) (Eosin)IBA 09/2023 - 10/2012
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 09/2006
6	Proto-Oncogene Proteins c-rafIBA 12/2013 - 05/2007
5	Hematoxylin (Haematoxylon)IBA 09/2023 - 05/2015
5	ParaffinIBA 07/2021 - 07/2010
5	Hyaluronic Acid (Hyaluronan)IBA 07/2021 - 10/2006
5	Phosphotransferases (Kinase)IBA 01/2019 - 03/2007
5	Calcibiotic Root Canal SealerIBA 01/2016 - 05/2007
5	Complement System Proteins (Complement)IBA 05/2015 - 12/2009
5	Cadherins (E-Cadherin)IBA 01/2015 - 01/2010
5	Peptide Hydrolases (Proteases)FDA Link 12/2011 - 09/2006
4	Tumor Biomarkers (Tumor Markers)IBA 06/2008 - 09/2006
3	Granzymes (Granzyme)IBA 09/2022 - 12/2009
3	Formaldehyde (Formol)FDA Link 07/2021 - 11/2014
3	LigandsIBA 01/2019 - 03/2010
3	MethyltransferasesIBA 01/2018 - 01/2012
3	Epithelial Cell Adhesion MoleculeIBA 01/2016 - 01/2004
3	Matrix Metalloproteinase 7 (Matrilysin)IBA 12/2011 - 08/2010
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2011 - 08/2006
3	beta CateninIBA 08/2010 - 10/2007
3	Mitogen-Activated Protein KinasesIBA 05/2007 - 08/2006
2	ArsenicIBA 07/2021 - 03/2011
2	AntibodiesIBA 01/2019 - 03/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2012
2	theasinensin AIBA 01/2018 - 04/2016
2	hyaluronan-mediated motility receptorIBA 09/2017 - 11/2015
2	RNA (Ribonucleic Acid)IBA 09/2017 - 01/2016
2	CytokinesIBA 11/2016 - 07/2014
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 08/2015 - 12/2010
2	CDX2 Transcription FactorIBA 05/2014 - 12/2011
2	AntigensIBA 01/2014 - 12/2009
2	CateninsIBA 12/2011 - 10/2010
2	Ephrin-B2 (Ephrin B2)IBA 12/2011 - 06/2008
2	EphB2 ReceptorIBA 12/2011 - 09/2005
2	Tryptases (Tryptase)IBA 09/2011 - 12/2010
2	Urokinase Plasminogen Activator ReceptorsIBA 01/2010 - 06/2009
2	Imatinib Mesylate (Gleevec)FDA Link 01/2005 - 11/2004
1	tyramine-deoxysorbitolIBA 11/2023
1	Coloring Agents (Dyes)IBA 09/2023
1	SolutionsIBA 01/2023
1	MucinsIBA 01/2022
1	Cathepsin BIBA 01/2019
1	Bevacizumab (Avastin)FDA Link 01/2019
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2019
1	Capecitabine (Xeloda)FDA Link 01/2019
1	Cetuximab (Erbitux)FDA Link 01/2019
1	VimentinIBA 01/2019
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2019
1	Caspase 3 (Caspase-3)IBA 02/2018
1	LMK-235IBA 01/2018
1	Decitabine FDA Link 01/2018
1	Histones (Histone)IBA 01/2018
1	trichostatin A (A 300)IBA 01/2018
1	Histone Deacetylase InhibitorsIBA 01/2018
1	InterferonsIBA 01/2017
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2017
1	Fluorouracil (Carac)FDA LinkGeneric 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	DNA Polymerase IIIBA 11/2016
1	N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA 04/2016
1	TensinsIBA 01/2016
1	Interleukin-33IBA 01/2016
1	InterleukinsIBA 01/2016

Therapy/Procedure

18	Therapeutics 07/2021 - 01/2004
4	Neoadjuvant Therapy 04/2024 - 01/2012
4	Immunotherapy 01/2023 - 01/2018
3	Drug Therapy (Chemotherapy) 01/2023 - 01/2017
3	Adjuvant Chemotherapy 07/2021 - 06/2008
2	Lasers (Laser) 01/2016 - 01/2015
1	Appendectomy 01/2023
1	Colectomy 01/2023